US doctor smeared for raising drug concerns
Pharma | Toxic substances

NewScientist.com news service
13 June 2007

When a well-respected doctor raises concerns about the side effects of an important medicine, you'd expect drug safety officials to investigate. Instead, a spokesman for the US Food and Drug Administration is alleged to have chosen a different strategy: smearing the doctor in question.

Steve Nissen, chair of cardiovascular medicine at the Cleveland Clinic in Ohio, investigated the safety of the diabetes drug Avandia, in a study published in The New England Journal of Medicine this March. Avandia is approved by the FDA, but Nissen found that it significantly increased the risk of heart attack. It was the latest blow to the FDA, which has been repeatedly criticised for failing to spot dangerous side effects.

According to ABC News, FDA spokesman Douglas Arbesfeld emailed health reporters drawing attention to a blog that accuses Nissen of focusing his criticism on drug manufacturers that do not run trials at the Cleveland Clinic - a charge Nissen rejects. The FDA declined to comment.

From issue 2607 of New Scientist magazine, 13 June 2007, page 7

Posted by sal on June 13, 2007 01:20 PM | Comments (0)




Comment this article

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)



Similar articles

  • GMO Myth: Argentina's GMO soy raising environment concerns - Jun 09, 2004
  • How Tightly Do Ties Between Doctor and Drug Company Bind? - Jul 27, 2004
  • Arthritis drug linked to heart problems - Jan 25, 2005
  • Thimerosal Concerns for Pets - Mar 03, 2004
  • More Concerns About Psychiatric Drugs Used by Children - May 24, 2006


    • FAIR USE NOTICE: This site may contain copyrighted (C ) material the use of which has not always been specifically authorized by the copyright owner. Such material is made available for educational purposes, to advance understanding of human rights, democracy, scientific, moral, ethical, and social justice issues, etc. It is believed that this constitutes a 'fair use' of any such copyrighted material as provided for in the 'fair use doctrine'. The material is distributed without profit.